In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus
Open Access
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 27 (5) , 974-985
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32-AI055400)
- Bill and Melinda Gates Foundation (OPP1163327)
This publication has 32 references indexed in Scilit:
- DNA vaccination protects mice against Zika virus-induced damage to the testesNature Communications, 2017
- Dengue Antibodies, then Zika: A Fatal Sequence in MiceImmunity, 2017
- A New Look at an Old Disease: Recent Insights into the Global Epidemiology of DengueCurrent Epidemiology Reports, 2017
- Zika Virus Causes Testis Damage and Leads to Male Infertility in MiceCell, 2016
- Zika virus infection damages the testes in miceNature, 2016
- Zika virus infection during the period of maximal brain growth causes microcephaly and corticospinal neuron apoptosis in wild type miceScientific Reports, 2016
- Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infectionScience, 2016
- Increasing genetic diversity of Zika virus in the Latin American outbreakEmerging Microbes & Infections, 2016
- Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapyScientific Reports, 2015
- Immunogenicity of mAbs in non-human primates during nonclinical safety assessmentmAbs, 2013